| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9767c30122d848de4d06ea0f898fd1da |
| publicationDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201642865-A |
| titleOfInvention |
4-(4-Fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfonimidomethyl)methyl]phenyl}-1,3,5-triter-2 -Use of amines in the treatment of gastric cancer |
| abstract |
The present invention relates to 4-(4-fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfonimidomethyl)methyl]phenyl}-1,3,5- Tris-2-amine (Compound A), more specifically (+)-4-(4-fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfonimide) Methyl]phenyl}-1,3,5-trioxan-2-amine (Compound A') is used for the treatment of gastric cancer, preferably gastric cancer in which the cells have C-MYC gene amplification. |
| priorityDate |
2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |